Further studies have shown that LPS affects various AD-related pathological products, including Aβ homeostasis, tau pathology, neuroinflammation, and neurodegeneration (Molinaro et al., 2020; Kim et al., 2021). Here, MAPT is linked to Alzheimer disease.